Biogen
BIIB
BIIB
964 hedge funds and large institutions have $46.5B invested in Biogen in 2016 Q2 according to their latest regulatory filings, with 107 funds opening new positions, 368 increasing their positions, 347 reducing their positions, and 79 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
6% less capital invested
Capital invested by funds: $49.3B → $46.5B (-$2.8B)
19% less call options, than puts
Call options by funds: $1.08B | Put options by funds: $1.33B
Holders
964
Holding in Top 10
43
Calls
$1.08B
Puts
$1.33B
Top Buyers
| 1 | +$721M | |
| 2 | +$246M | |
| 3 | +$198M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$136M |
| 5 |
CCM
Causeway Capital Management
Los Angeles,
California
|
+$135M |
Top Sellers
| 1 | -$3.41B | |
| 2 | -$496M | |
| 3 | -$424M | |
| 4 |
Jennison Associates
New York
|
-$353M |
| 5 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$226M |